ANNUAL REPORT
View an enhanced version of our Annual Report.
PROXY STATEMENT
View an enhanced version of our Proxy Statement.
INFORMATION STATEMENT
View an enhanced version of our Information Statement.
The secure way to view our annual documents and vote your shares.
View an enhanced version of our Annual Report.
View an enhanced version of our Proxy Statement.
View an enhanced version of our Information Statement.
Your vote is Important!
Please be sure to vote online now or by phone by dialing 844-209-9557.
June 10, 2021
9:30 AM Pacific Time
REGISTRATION DEADLINE:
June 8, 2021
5:00 PM Pacific Time
Note: You must register by the deadline to be eligible to participate in the meeting.
ImmunityBio, Inc. and NantKwest, Inc. merged on March 9, 2021 to create a leading late-stage, cell therapy and immunotherapy company focused on oncology and infectious diseases. The combined company is called ImmunityBio, Inc. (NASDAQ: IBRX).
